Skip to main content

MTNB

Stock
Health Care
Biotechnology

Performance overview

MTNB Price
Price Chart

Forward-looking statistics

Beta
1.14
Risk
100.00%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.

Company info

SectorHealth Care
IndustryBiotechnology
Employees31
Market cap$39.9M

Fundamentals

Enterprise value$317.4K
Revenue$0.0
Revenue per employee
Profit margin0.00%
Debt to equity43.28

Security info

ExchangeNyse American
Type of shareCommon Stock
Earnings per share (EPS)-$3.97
Dividend per share
Revenue per share$0.00
Avg trading volume (30 day)$363K
Avg trading volume (10 day)$99K
Put-call ratio

Macro factor sensitivity

Growth-1.2
Credit+1.8
Liquidity-1.6
Inflation-1.6
Commodities-1.1
Interest Rates+0.2

Valuation

Dividend yield0.00%
PEG Ratio-0.31
Price to sales
P/E Ratio-0.31
Enterprise Value to Revenue
Price to book0.74

Upcoming events

Next earnings dayApril 16, 2025
Next dividend day
Ex. dividend day

News

Matinas Biopharma Holdings, Inc. (MTNB) Reports Q1 Loss, Tops Revenue Estimates

Matinas Biopharma Holdings, Inc. (MTNB) came out with a quarterly loss of $0.03 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.03 per share a year ago.

Zacks Investment Research (May 10, 2023)
Matinas BioPharma Inks mRNA-Based Vaccine Pact With BioNTech

BioNTech SE (NASDAQ: BNTX) and Matinas BioPharma Holdings Inc (NYSE: MTNB) have entered into an exclusive research collaboration to evaluate the combination of mRNA formats and Matinas' proprietary LNC platform technology.  The companies will collaborate on.

Benzinga (April 11, 2022)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free